Functional characterization of nucleoside transporter gene replacements in Leishmania donovani

Wei Liu, Jan M. Boitz, Jon Galazka, Cassandra S. Arendt, Nicola Carter, Buddy Ullman

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Leishmania donovani express two nucleoside transporters of non-overlapping ligand selectivity. To evaluate the physiological role of nucleoside transporters in L. donovani, homozygous null mutants of the genes encoding the LdNT1 adenosine-pyrimidine nucleoside transporter and the LdNT2 inosine-guanosine transporter were created singly and in combination by single targeted gene replacement followed by selection for loss-of-heterozygosity. The mutant alleles were verified by Southern blotting, and the effects of gene replacement on transport phenotype were evaluated by rapid sampling transport measurements and by drug resistance profiles. The Δldnt1, Δldnt2, and Δldnt1/Δldnt2 mutants were all capable of proliferation in defined culture medium supplemented with any of a spectrum of purine nucleobases or nucleosides, except that a Δldnt2 lesion conferred an inability to efficiently salvage exogenous xanthosine, a newly discovered ligand of LdNT2. Each of the three knockout strains was viable as promastigotes and axenic amastigotes and capable of maintaining an infection in J774 and bone marrow-derived murine macrophages. These genetic studies demonstrate: (1) that L. donovani promastigotes, axenic amastigotes, and tissue amastigotes are viable in the absence of nucleoside transport; (2) that nucleoside transporters are not essential for sustaining an infection in mammalian host cells; (3) that the phagolysosome of macrophages is likely to contain purines that are not LdNT1 or LdNT2 ligands, i.e., nucleobases. Furthermore, the Δldnt1, Δldnt2, and Δldnt1/Δldnt2 knockouts offer a unique genetically defined null background for the biochemical and genetic characterization of nucleoside transporter genes and cDNAs from phylogenetically diverse species and of genetically manipulated LdNT1 and LdNT2 constructs.

Original languageEnglish (US)
Pages (from-to)300-307
Number of pages8
JournalMolecular and Biochemical Parasitology
Volume150
Issue number2
DOIs
StatePublished - Dec 2006

Fingerprint

Nucleoside Transport Proteins
Leishmania donovani
Genes
Ligands
Nucleosides
Macrophages
Pyrimidine Nucleosides
Phagosomes
Inosine
Purines
Guanosine
Loss of Heterozygosity
Southern Blotting
Infection
Drug Resistance
Adenosine
Culture Media
Molecular Biology
Complementary DNA
Alleles

Keywords

  • Infectivity
  • Purines
  • Pyrimidines
  • Transport
  • Transporters

ASJC Scopus subject areas

  • Molecular Biology
  • Parasitology

Cite this

Functional characterization of nucleoside transporter gene replacements in Leishmania donovani. / Liu, Wei; Boitz, Jan M.; Galazka, Jon; Arendt, Cassandra S.; Carter, Nicola; Ullman, Buddy.

In: Molecular and Biochemical Parasitology, Vol. 150, No. 2, 12.2006, p. 300-307.

Research output: Contribution to journalArticle

Liu, Wei ; Boitz, Jan M. ; Galazka, Jon ; Arendt, Cassandra S. ; Carter, Nicola ; Ullman, Buddy. / Functional characterization of nucleoside transporter gene replacements in Leishmania donovani. In: Molecular and Biochemical Parasitology. 2006 ; Vol. 150, No. 2. pp. 300-307.
@article{7421b62edade411cbee058f77c2e7f42,
title = "Functional characterization of nucleoside transporter gene replacements in Leishmania donovani",
abstract = "Leishmania donovani express two nucleoside transporters of non-overlapping ligand selectivity. To evaluate the physiological role of nucleoside transporters in L. donovani, homozygous null mutants of the genes encoding the LdNT1 adenosine-pyrimidine nucleoside transporter and the LdNT2 inosine-guanosine transporter were created singly and in combination by single targeted gene replacement followed by selection for loss-of-heterozygosity. The mutant alleles were verified by Southern blotting, and the effects of gene replacement on transport phenotype were evaluated by rapid sampling transport measurements and by drug resistance profiles. The Δldnt1, Δldnt2, and Δldnt1/Δldnt2 mutants were all capable of proliferation in defined culture medium supplemented with any of a spectrum of purine nucleobases or nucleosides, except that a Δldnt2 lesion conferred an inability to efficiently salvage exogenous xanthosine, a newly discovered ligand of LdNT2. Each of the three knockout strains was viable as promastigotes and axenic amastigotes and capable of maintaining an infection in J774 and bone marrow-derived murine macrophages. These genetic studies demonstrate: (1) that L. donovani promastigotes, axenic amastigotes, and tissue amastigotes are viable in the absence of nucleoside transport; (2) that nucleoside transporters are not essential for sustaining an infection in mammalian host cells; (3) that the phagolysosome of macrophages is likely to contain purines that are not LdNT1 or LdNT2 ligands, i.e., nucleobases. Furthermore, the Δldnt1, Δldnt2, and Δldnt1/Δldnt2 knockouts offer a unique genetically defined null background for the biochemical and genetic characterization of nucleoside transporter genes and cDNAs from phylogenetically diverse species and of genetically manipulated LdNT1 and LdNT2 constructs.",
keywords = "Infectivity, Purines, Pyrimidines, Transport, Transporters",
author = "Wei Liu and Boitz, {Jan M.} and Jon Galazka and Arendt, {Cassandra S.} and Nicola Carter and Buddy Ullman",
year = "2006",
month = "12",
doi = "10.1016/j.molbiopara.2006.09.002",
language = "English (US)",
volume = "150",
pages = "300--307",
journal = "Molecular and Biochemical Parasitology",
issn = "0166-6851",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Functional characterization of nucleoside transporter gene replacements in Leishmania donovani

AU - Liu, Wei

AU - Boitz, Jan M.

AU - Galazka, Jon

AU - Arendt, Cassandra S.

AU - Carter, Nicola

AU - Ullman, Buddy

PY - 2006/12

Y1 - 2006/12

N2 - Leishmania donovani express two nucleoside transporters of non-overlapping ligand selectivity. To evaluate the physiological role of nucleoside transporters in L. donovani, homozygous null mutants of the genes encoding the LdNT1 adenosine-pyrimidine nucleoside transporter and the LdNT2 inosine-guanosine transporter were created singly and in combination by single targeted gene replacement followed by selection for loss-of-heterozygosity. The mutant alleles were verified by Southern blotting, and the effects of gene replacement on transport phenotype were evaluated by rapid sampling transport measurements and by drug resistance profiles. The Δldnt1, Δldnt2, and Δldnt1/Δldnt2 mutants were all capable of proliferation in defined culture medium supplemented with any of a spectrum of purine nucleobases or nucleosides, except that a Δldnt2 lesion conferred an inability to efficiently salvage exogenous xanthosine, a newly discovered ligand of LdNT2. Each of the three knockout strains was viable as promastigotes and axenic amastigotes and capable of maintaining an infection in J774 and bone marrow-derived murine macrophages. These genetic studies demonstrate: (1) that L. donovani promastigotes, axenic amastigotes, and tissue amastigotes are viable in the absence of nucleoside transport; (2) that nucleoside transporters are not essential for sustaining an infection in mammalian host cells; (3) that the phagolysosome of macrophages is likely to contain purines that are not LdNT1 or LdNT2 ligands, i.e., nucleobases. Furthermore, the Δldnt1, Δldnt2, and Δldnt1/Δldnt2 knockouts offer a unique genetically defined null background for the biochemical and genetic characterization of nucleoside transporter genes and cDNAs from phylogenetically diverse species and of genetically manipulated LdNT1 and LdNT2 constructs.

AB - Leishmania donovani express two nucleoside transporters of non-overlapping ligand selectivity. To evaluate the physiological role of nucleoside transporters in L. donovani, homozygous null mutants of the genes encoding the LdNT1 adenosine-pyrimidine nucleoside transporter and the LdNT2 inosine-guanosine transporter were created singly and in combination by single targeted gene replacement followed by selection for loss-of-heterozygosity. The mutant alleles were verified by Southern blotting, and the effects of gene replacement on transport phenotype were evaluated by rapid sampling transport measurements and by drug resistance profiles. The Δldnt1, Δldnt2, and Δldnt1/Δldnt2 mutants were all capable of proliferation in defined culture medium supplemented with any of a spectrum of purine nucleobases or nucleosides, except that a Δldnt2 lesion conferred an inability to efficiently salvage exogenous xanthosine, a newly discovered ligand of LdNT2. Each of the three knockout strains was viable as promastigotes and axenic amastigotes and capable of maintaining an infection in J774 and bone marrow-derived murine macrophages. These genetic studies demonstrate: (1) that L. donovani promastigotes, axenic amastigotes, and tissue amastigotes are viable in the absence of nucleoside transport; (2) that nucleoside transporters are not essential for sustaining an infection in mammalian host cells; (3) that the phagolysosome of macrophages is likely to contain purines that are not LdNT1 or LdNT2 ligands, i.e., nucleobases. Furthermore, the Δldnt1, Δldnt2, and Δldnt1/Δldnt2 knockouts offer a unique genetically defined null background for the biochemical and genetic characterization of nucleoside transporter genes and cDNAs from phylogenetically diverse species and of genetically manipulated LdNT1 and LdNT2 constructs.

KW - Infectivity

KW - Purines

KW - Pyrimidines

KW - Transport

KW - Transporters

UR - http://www.scopus.com/inward/record.url?scp=33751076833&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751076833&partnerID=8YFLogxK

U2 - 10.1016/j.molbiopara.2006.09.002

DO - 10.1016/j.molbiopara.2006.09.002

M3 - Article

C2 - 17050001

AN - SCOPUS:33751076833

VL - 150

SP - 300

EP - 307

JO - Molecular and Biochemical Parasitology

JF - Molecular and Biochemical Parasitology

SN - 0166-6851

IS - 2

ER -